abstract |
The present invention relates to the use of activin-ACTRIIA antagonists and promoting bone growth in cancer patients. In certain aspects, the present invention provides compositions and methods for promoting bone growth and increasing bone density, and treating multiple myeloma, wherein the compositions comprise the activin-ACTRIIA antagonist. |